Critics say it can't tell conception oddsA new medical test for women who want to check their biological clocks is debuting in Chicago amid concerns about its usefulness and enormous interest in the consequences of delayed childbearing.
Called Plan Ahead, it is the first fertility test that purports to measure a woman's "ovarian reserve"—how many good eggs she has available for conception.
The $350 test will be marketed to women who are contemplating when to have children and who want to recognize any potential biological limitations.
...
"Will this tell a woman will she or will she not become pregnant? No, it will not, and I'm not sure what the value is," said Dr. Zev Rosenwaks, director of the Center for Reproductive Medicine and Infertility at New York Weill Cornell Medical Center.
Chicago Tribune